All articles by GlobalData Healthcare

  1. The world is getting better, look no further than vaccines

    In a world where good news is in short supply, the global vaccine space offers a healthy dose of optimism…
    Read More…

    15 Feb
  2. AstraZeneca hopes FDA breakthrough therapy can rise above a string of recent failures

    On 5 February, the US Food and Drug Administration granted a Breakthrough Therapy designation to AstraZeneca’s MEDI8897, an investigational monoclonal…
    Read More…

    14 Feb
  3. Checkered data hinders Reata’s bardoxolone Phase II prospects

    Reata Pharmaceuticals’ Phase II pursuit of bardoxolone in focal segmental glomerulosclerosis (FSGS) may be thwarted given proteinuria increases seen in…
    Read More…

    12 Feb
  4. Why Cosentyx will claim top spot in plaque psoriasis market by 2027

    Recently published clinical results suggest patients undergoing Cosentyx treatment for plaque psoriasis have shown marked improvement after four weeks, leading…
    Read More…

    12 Feb
  5. Even if approved Amgen’s biosimilar will have an uphill battle

    Most experts remain sceptical that, if approved, Amgen’s ABP 959, a biosimilar of Alexion Pharmaceuticals’ Soliris, will achieve strong market…
    Read More…

    12 Feb
  6. Roche’s Phase III Alban trial has five patients so far, source says

    Roche’s Phase III Alban trial investigating Tecentriq (atezolizumab) in combination with BCG vaccine in high-risk, non-muscle invasive bladder cancer has…
    Read More…

    12 Feb
  7. Price war expected to encourage uptake of PCSK9

    Price slashing last year by cholesterol-lowering PCSK9 drug developers is expected to improve affordability and promote uptake of inhibitors in…
    Read More…

    11 Feb
  8. Bio-Thera’s Phase III trials have biosimilar to Actemra in its sights

    Guangzhou-based biotechnology company Bio-Thera Solutions Ltd announced the initiation of its Phase III clinical trial for BAT1806 on 23 January….
    Read More…

    11 Feb
  9. Restoring neurological function after a stroke takes centre stage

    Currently the treatment of acute ischemic stroke (AIS) – the most common form of stroke – is focused on restoration…
    Read More…

    8 Feb
  10. Immuno-oncology sees solid growth spurt

    Immuno-oncology, that branch of medicine that looks to stimulate the body’s natural defences to fight cancer, enjoyed a solid run…
    Read More…

    8 Feb

Go Top